IDX — Integral Diagnostics Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual income statement for Integral Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	R2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	361	441	470	628	789
Cost of Revenue
Gross Profit	342	420	447	600	753
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	328	392	505	591	724
Operating Profit	33.2	48.9	-35.4	36.6	64.5
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	22.6	30.6	-57.1	8.82	32.1
Provision for Income Taxes
Net Income After Taxes	14.6	25	-60.7	2.83	22
Minority Interest
Net Income Before Extraordinary Items
Net Income	14.6	25	-60.7	2.69	21.9
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	14.6	25	-60.7	2.69	21.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.086	0.075	-0.044	0.094	0.107
Dividends per Share